News

By Carole Tanzer Miller HealthDay ReporterSATURDAY, August 2, 2025 (HealthDay News) — To fend off predators, millipedes ...
A study found that the proportion of Parkinson's disease patients who used oriental medicine more than once increased by 65% ...
Gene Mack, CEO, GAIN Therapeutics, shares how growing clinician confidence and strong early experiences helped accelerate ...
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford scientists reporting improvement in neuron communication in mice.
About 90,000 people are diagnosed with Parkinson's disease (PD) each year—one person every six minutes. While most people ...
Insightec, the Miami-based innovator in focused ultrasound to transform patient care, announced July 8 the U.S. Food and Drug ...
According to a study published in the international journal, the number of Parkinson's disease patients worldwide is expected ...
Ozzy Osbourne, Black Sabbath frontman, has died at the age of 76. He had suffered from numerous health problems and was ...
Gait changes such as swinging the arms differently and taking smaller, slower steps ...
Scientists have developed a long-acting injectable treatment combining levodopa and carbidopa, the two medications used to treat Parkinson’s, which could transform how the disease is treated.
A University of Bristol study shows that trained dogs can detect Parkinson's disease with 80% sensitivity by identifying ...
Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are caused by genetics, the cause is unknown in most.